Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02059213
Title A Phase II Study of Androgen Deprivation Therapy With or Without PD 0332991 in RB-Positive Metastatic Prostate Cancer
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors University of Michigan Cancer Center
Indications

prostate cancer

Therapies

Goserelin

Palbociclib

Bicalutamide

Leuprolide

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Cancer Center Duarte California 91010 United States Details
Northwestern University Chicago Illinois 60611 United States Details
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231 United States Details
University of Michigan Hospital Ann Arbor Michigan 48109 United States Details
Washington University in St. Louis Saint Louis Missouri 63110 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 United States Details
Huntsman Cancer Institute, University of Utah Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field